Month: December 2022

A collaboration between Re:Cognition Health and MYndspan is helping to improve access to data-driven insights into brain health, for patients across London.

The partnership will see MYndspan’s technology used at Re:Cognition Health’s London clinic, which can help assess and measure brain health in under an hour.

The 45-minute service is powered by a non-invasive scanning technology called magnetoencephalography (MEG). MEG is capable of measuring electrical signals between neurons in order to create a detailed map of brain activity. Alongside this, the service also uses app-based games to test cognitive function.

Dr Emer MacSweeney, CEO of Re:Cognition Health Ltd and consultant neuroradiologist, said: “MYndspan’s data-driven quantification of brain health using MEG technology is ground-breaking. Our brain and mind experts at Re:Cognition Health are confident MYndspan’s data-led insights will not only help to inform the care we provide for our patients, but also empower individuals with their own data.

“A better understanding

Pharma data intelligence firm Acxiom is working with Treasure Data to launch HCP Engage – a platform that connects data from disparate sources and offers pharmaceutical marketers an easy, no-code way of delivering on personalisation efforts.

The marketing platform is designed to help pharma companies make deeper connections with healthcare professionals in a way that can improve patient outcomes.

The company says it aims to cut through the noise that is typically part of healthcare professionals (HCP)’s day when they’re trying to research healthcare advancements and new medications.

HCP Engage is claimed to allow pharma marketers to build a unified HCP view that is based on engagement history, demographics and interactions with content. With that unified customer view Treasure Cloud’s Customer Data Cloud then helps marketers to build HCP audiences based on product, behavioural and HCP insights.

The final step is to activate that data across marketing platforms, including web,

Researchers at Binghamton University have developed a microbial fuel cell that can power ingestible devices, such as cameras, that can detect health issues in the gastrointestinal tract, and specifically within the small intestine. The fuel cell contains dormant Bacillus subtilis endospores that only germinate and become active when they encounter nutrient-rich intestinal fluid. Another check on activity is a pH-sensitive membrane that only allows the fuel cell to activate when it reaches the neutral pH of the small intestine. The technology may provide an alternative to conventional batteries that could pose a health risk if they began to leak or became damaged in the body.

How can we monitor the intestine? One option is an ingestible camera in the form of a pill that once swallowed will pass down the gastrointestinal tract and provide invaluable images of those difficult-to-reach areas. While this solution is elegant, finding a way to reliably

A Graphnet digital version of the Recommended Summary Plan for Emergency Care and Treatment (ReSPECT) has been accredited for use.

As a result, an individual’s emergency care and treatment plan will be available – in real-time – as part of the CareCentric Shared Care Record. Having ReSPECT available in a digital format means that clinicians and health and care teams can access and view it at any time.

A ReSPECT plan details personalised recommendations for clinical care and treatment in the event of the patient not being able to communicate this for themselves. It may include what matters most to the patients, as well as what is realistic in terms of their care and treatment.

Graphnet has worked closely with the Resuscitation Council to create a digitised version of the current 3.5 version of the paper-based ReSPECT plan. The digital plan can be stored and accessed within the Care

Solent NHS Trust is piloting digital wards in conjunction with Doccla, offering patients with frailty personalised care to help reduce hospital admissions.

The new virtual wards will be available to patients across Portsmouth and Southampton with suspected or known frailty. Patients are closely monitored and reviewed daily from their own home, once accepted into the virtual wards programme. Treatment is adjusted when needed and the service is fully integrated with SystmOne.

Doccla’s technology is delivered through a mobile app and clinical dashboard through a provided device.

Solent NHS Trust chief medical officer Dr Dan Baylis said: “We are really excited to be piloting this type of virtual wards in Portsmouth and Southampton with the digital expertise of Doccla. 

“Virtual wards, running across the country, provide a suitable and safe alternative to hospital care. The use of technology is largely untapped to date in terms of this patient group, so